Palmar plantar erythrodysesthesia historical perspective: Difference between revisions
Jump to navigation
Jump to search
Mchitsazan (talk | contribs) No edit summary |
Mchitsazan (talk | contribs) |
||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
In 1974, Zuehlke was the first to describe PPE in a patient receiving mitotane for hypernephroma. | In 1974, Zuehlke was the first to describe PPE in a patient receiving mitotane for hypernephroma. | ||
==Historical Perspective== | ==Historical Perspective== | ||
Revision as of 14:41, 1 July 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Mandana Chitsazan, M.D.
Overview
In 1974, Zuehlke was the first to describe PPE in a patient receiving mitotane for hypernephroma.
Historical Perspective
In 1974, Zuehlke was the first to describe PPE in a patient receiving mitotane for hypernephroma.[1]
References
- ↑ R. L. Zuehlke. "Erythematous eruption of the palms and soles associated with mitotane therapy". Dermatologica. PMID 4276191.